Triamcinolone diacetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triamcinolone diacetate and what is the scope of freedom to operate?
Triamcinolone diacetate
is the generic ingredient in three branded drugs marketed by Fosun Pharma, Epic Pharma Llc, Watson Labs, Astellas, and Delcor Asset Corp, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for triamcinolone diacetate.
Summary for triamcinolone diacetate
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 5 |
NDAs: | 8 |
Drug Master File Entries: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Patent Applications: | 3,359 |
DailyMed Link: | triamcinolone diacetate at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for triamcinolone diacetate
US Patents and Regulatory Information for triamcinolone diacetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Delcor Asset Corp | KENACORT | triamcinolone diacetate | SYRUP;ORAL | 012515-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fosun Pharma | ARISTOCORT | triamcinolone diacetate | INJECTABLE;INJECTION | 012802-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | TRIAMCINOLONE DIACETATE | triamcinolone diacetate | INJECTABLE;INJECTION | 085529-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astellas | ARISTOCORT | triamcinolone diacetate | SYRUP;ORAL | 011960-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |